- Home
- NVVE vs QNRX Comparison
NVVE vs QNRX Comparison
Compare NVVE & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- QNRX
- Stock Information
- Founded
- NVVE 1996
- QNRX 2018
- Country
- NVVE United States
- QNRX United States
- Employees
- NVVE N/A
- QNRX N/A
- Industry
- NVVE Oil Refining/Marketing
- QNRX Medical/Dental Instruments
- Sector
- NVVE Energy
- QNRX Health Care
- Exchange
- NVVE Nasdaq
- QNRX Nasdaq
- Market Cap
- NVVE 4.2M
- QNRX 4.4M
- IPO Year
- NVVE N/A
- QNRX N/A
- Fundamental
- Price
- NVVE $0.25
- QNRX $7.60
- Analyst Decision
- NVVE
- QNRX
- Analyst Count
- NVVE 0
- QNRX 0
- Target Price
- NVVE N/A
- QNRX N/A
- AVG Volume (30 Days)
- NVVE 5.1M
- QNRX 2.5K
- Earning Date
- NVVE 11-11-2025
- QNRX 11-06-2025
- Dividend Yield
- NVVE N/A
- QNRX N/A
- EPS Growth
- NVVE N/A
- QNRX N/A
- EPS
- NVVE N/A
- QNRX N/A
- Revenue
- NVVE $4,949,747.00
- QNRX N/A
- Revenue This Year
- NVVE $892.33
- QNRX N/A
- Revenue Next Year
- NVVE N/A
- QNRX N/A
- P/E Ratio
- NVVE N/A
- QNRX N/A
- Revenue Growth
- NVVE N/A
- QNRX N/A
- 52 Week Low
- NVVE $0.18
- QNRX $5.01
- 52 Week High
- NVVE $8.76
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- NVVE 29.80
- QNRX 52.41
- Support Level
- NVVE $0.23
- QNRX $7.37
- Resistance Level
- NVVE $0.28
- QNRX $7.79
- Average True Range (ATR)
- NVVE 0.06
- QNRX 0.14
- MACD
- NVVE -0.00
- QNRX 0.05
- Stochastic Oscillator
- NVVE 23.13
- QNRX 73.24
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.